StockData
MannKind Corp logo

MannKind Corp (MNKD) stock

MNKDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30120% above fair value
$3.96−0.17 (-4.24%)

Close on Nov 16, 2026Market cap $1.27BP/E –Yield –

MannKind total assets

Total assets on the balance sheet at the end of each period.

MannKind's total assets was $732.30M at Jun 30, 2026. For fiscal 2025 it was $792.18M, up 101.1% from the year before. Over ten years it grew 20.1% a year on average. The highest annual figure on record is $792.18M in fiscal 2025.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$792.18M+101.1%
FY2024Dec 31, 2024$393.84M-17.1%
FY2023Dec 31, 2023$475.20M+60.9%
FY2022Dec 31, 2022$295.28M-8.1%
FY2021Dec 31, 2021$321.16M+195.7%
FY2020Dec 31, 2020$108.61M+15.9%
FY2019Dec 31, 2019$93.73M-13.0%
FY2018Dec 31, 2018$107.71M+27.3%
FY2017Dec 31, 2017$84.58M-21.0%
FY2016Dec 31, 2016$107.06M-15.3%
FY2015Dec 31, 2015$126.41M-68.0%
FY2014Dec 31, 2014$394.44M+52.5%
FY2013Dec 31, 2013$258.65M+2.9%
FY2012Dec 31, 2012$251.31M+25.9%
FY2011Dec 31, 2011$199.55M-28.0%
FY2010Dec 31, 2010$277.26M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$732.30M+77.9%
Q1 FY2026Mar 31, 2026$744.40M+81.5%
Q4 FY2025Dec 31, 2025$792.18M+101.1%
Q3 FY2025Sep 30, 2025$494.64M+6.6%
Q2 FY2025Jun 30, 2025$411.70M-7.2%
Q1 FY2025Mar 31, 2025$410.14M-14.7%
Q4 FY2024Dec 31, 2024$393.84M-17.1%
Q3 FY2024Sep 30, 2024$464.20M+44.9%
Q2 FY2024Jun 30, 2024$443.84M+41.6%
Q1 FY2024Mar 31, 2024$480.88M+61.3%
Q4 FY2023Dec 31, 2023$475.20M+60.9%
Q3 FY2023Sep 30, 2023$320.33M+9.0%
Q2 FY2023Jun 30, 2023$313.42M+9.7%
Q1 FY2023Mar 31, 2023$298.14M-3.3%
Q4 FY2022Dec 31, 2022$295.28M-8.1%
Q3 FY2022Sep 30, 2022$293.84M+23.4%
Q2 FY2022Jun 30, 2022$285.80M+13.1%
Q1 FY2022Mar 31, 2022$308.32M-3.5%
Q4 FY2021Dec 31, 2021$321.16M+195.7%
Q3 FY2021Sep 30, 2021$238.21M+149.0%
Q2 FY2021Jun 30, 2021$252.79M+146.0%
Q1 FY2021Mar 31, 2021$319.38M+298.2%
Q4 FY2020Dec 31, 2020$108.61M+15.9%
Q3 FY2020Sep 30, 2020$95.68M+0.6%
Q2 FY2020Jun 30, 2020$102.78M+25.7%
Q1 FY2020Mar 31, 2020$80.21M-20.6%
Q4 FY2019Dec 31, 2019$93.73M-13.0%
Q3 FY2019Sep 30, 2019$95.14M+109.8%
Q2 FY2019Jun 30, 2019$81.80M+31.6%
Q1 FY2019Mar 31, 2019$100.96M+63.2%
Q4 FY2018Dec 31, 2018$107.71M+27.3%
Q3 FY2018Sep 30, 2018$45.36M-19.7%
Q2 FY2018Jun 30, 2018$62.16M-21.7%
Q1 FY2018Mar 31, 2018$61.88M-27.4%
Q4 FY2017Dec 31, 2017$84.58M-21.0%
Q3 FY2017Sep 30, 2017$56.48M-41.2%
Q2 FY2017Jun 30, 2017$79.37M–
Q1 FY2017Mar 31, 2017$85.19M–
Q4 FY2016Dec 31, 2016$107.06M–
Q3 FY2016Sep 30, 2016$96.13M–

More MannKind figures

See a number that looks wrong?